CSL CEO on Financial Results, Business Outlook

REPLAY VIDEO
Your next video will start in
Pause

Recommended Videos

  • Info

  • Comments

Feb. 12 (Bloomberg) -- Paul Perreault, chief executive officer of CSL Ltd., Australia's biggest pharmaceutical company, talks about its financial results and business outlook. CSL reported a 3.4 percent increase in first-half profit, helped by surging sales of an antidote for the blood-thinner warfarin. Perreault speaks from Melbourne with Angie Lau on Bloomberg Television's "First Up." (Source: Bloomberg)

Advertisement

BTV Channel Finder

Channel_finder_loader

ZIP is required for U.S. locations

Bloomberg Television in   change